XML 20 R46.htm IDEA: XBRL DOCUMENT v2.4.1.9
Intangible Assets and Royalty Agreement (Details) (USD $)
In Thousands, unless otherwise specified
 12 Months Ended 0 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Jan. 29, 2007
Jan. 05, 2011
Finite-Lived Intangible Assets [Line Items]          
Intangible Assets, Gross Carrying Value $ 14,776us-gaap_IntangibleAssetsGrossExcludingGoodwill $ 14,182us-gaap_IntangibleAssetsGrossExcludingGoodwill      
Less Accumulated amortization (3,931)mdxg_IntangibleAssetsAccumulatedAmortization (3,003)mdxg_IntangibleAssetsAccumulatedAmortization      
Intangible Assets, Net 10,845us-gaap_IntangibleAssetsNetExcludingGoodwill 11,179us-gaap_IntangibleAssetsNetExcludingGoodwill      
Net book value 9,837us-gaap_FiniteLivedIntangibleAssetsNet        
Amortization of intangible assets 928us-gaap_AmortizationOfIntangibleAssets 1,054us-gaap_AmortizationOfIntangibleAssets 1,380us-gaap_AmortizationOfIntangibleAssets    
Estimated future amortization expense [Abstract]          
2015 929us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths        
2016 929us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo        
2017 840us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree        
2018 830us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour        
2019 830us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive        
Thereafter 5,479us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive        
Net book value 9,837us-gaap_FiniteLivedIntangibleAssetsNet        
Tradenames & Trademarks          
Finite-Lived Intangible Assets [Line Items]          
Gross Carrying Value, Indefinite Lived 1,008us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill
/ us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TrademarksAndTradeNamesMember		 1,008us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill
/ us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TrademarksAndTradeNamesMember		      
Tradenames & Trademarks | Surgical Biologics, LLC          
Finite-Lived Intangible Assets [Line Items]          
Gross Carrying Value, Indefinite Lived         1,008us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill
/ us-gaap_CounterpartyNameAxis
= mdxg_SurgicalBiologicsMember
/ us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_TrademarksAndTradeNamesMember
In Process Research & Development          
Finite-Lived Intangible Assets [Line Items]          
Gross Carrying Value, Indefinite Lived 25us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill
/ us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_InProcessResearchAndDevelopmentMember		 25us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill
/ us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_InProcessResearchAndDevelopmentMember		      
In Process Research & Development | Surgical Biologics, LLC          
Finite-Lived Intangible Assets [Line Items]          
Gross Carrying Value, Indefinite Lived         25us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill
/ us-gaap_CounterpartyNameAxis
= mdxg_SurgicalBiologicsMember
/ us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_InProcessResearchAndDevelopmentMember
Patents in Process          
Finite-Lived Intangible Assets [Line Items]          
Gross Carrying Value, Indefinite Lived 1,082us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill
/ us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis
= mdxg_PatentsinProcessMember		 580us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill
/ us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis
= mdxg_PatentsinProcessMember		      
Licenses          
Finite-Lived Intangible Assets [Line Items]          
Weighted Average Amortization Lives 10 years [1],[2],[3]        
Gross Carrying Value 1,009us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_LicensingAgreementsMember		 [1],[2],[3] 1,009us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_LicensingAgreementsMember		 [1],[2],[3]      
Licenses | Shriners Hospitals for Children and University of South Florida Research Foundation, Inc.          
Finite-Lived Intangible Assets [Line Items]          
Acquisition price       996us-gaap_PaymentsToAcquireIntangibleAssets
/ us-gaap_CounterpartyNameAxis
= mdxg_ShrinersHospitalsForChildrenAndUniversityOfSouthFloridaResearchFoundationInc.Member
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_LicensingAgreementsMember		  
Maximum time of approval       30 days  
Contingent payments to licensor 200us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
/ us-gaap_CounterpartyNameAxis
= mdxg_ShrinersHospitalsForChildrenAndUniversityOfSouthFloridaResearchFoundationInc.Member
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_LicensingAgreementsMember		        
Contingent royalty to be paid to licensor 3.00%mdxg_ContingentRoyaltyToBePaidToLicensor
/ us-gaap_CounterpartyNameAxis
= mdxg_ShrinersHospitalsForChildrenAndUniversityOfSouthFloridaResearchFoundationInc.Member
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_LicensingAgreementsMember		        
Annual royalty payment       50us-gaap_RoyaltyExpense
/ us-gaap_CounterpartyNameAxis
= mdxg_ShrinersHospitalsForChildrenAndUniversityOfSouthFloridaResearchFoundationInc.Member
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_LicensingAgreementsMember		  
Net book value 209us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_CounterpartyNameAxis
= mdxg_ShrinersHospitalsForChildrenAndUniversityOfSouthFloridaResearchFoundationInc.Member
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_LicensingAgreementsMember		        
Estimated future amortization expense [Abstract]          
Net book value 209us-gaap_FiniteLivedIntangibleAssetsNet
/ us-gaap_CounterpartyNameAxis
= mdxg_ShrinersHospitalsForChildrenAndUniversityOfSouthFloridaResearchFoundationInc.Member
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_LicensingAgreementsMember		        
Licenses | Surgical Biologics, LLC          
Finite-Lived Intangible Assets [Line Items]          
Gross Carrying Value         13us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_CounterpartyNameAxis
= mdxg_SurgicalBiologicsMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_LicensingAgreementsMember		 [1],[2],[3]
Patents & Know How          
Finite-Lived Intangible Assets [Line Items]          
Weighted Average Amortization Lives 17 years        
Gross Carrying Value 7,891us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_PatentsMember		 7,799us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_PatentsMember		      
Patents & Know How | Surgical Biologics, LLC          
Finite-Lived Intangible Assets [Line Items]          
Gross Carrying Value         7,690us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_CounterpartyNameAxis
= mdxg_SurgicalBiologicsMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_PatentsMember
Finite-Lived Intangible Assets, Costs 92us-gaap_FinitelivedIntangibleAssetsAcquired1
/ us-gaap_CounterpartyNameAxis
= mdxg_SurgicalBiologicsMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_PatentsMember		        
Customer & Supplier Relationships          
Finite-Lived Intangible Assets [Line Items]          
Weighted Average Amortization Lives 14 years        
Gross Carrying Value 3,761us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerRelationshipsMember		 3,761us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerRelationshipsMember		      
Customer & Supplier Relationships | Surgical Biologics, LLC          
Finite-Lived Intangible Assets [Line Items]          
Gross Carrying Value         $ 3,761us-gaap_FiniteLivedIntangibleAssetsGross
/ us-gaap_CounterpartyNameAxis
= mdxg_SurgicalBiologicsMember
/ us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis
= us-gaap_CustomerRelationshipsMember
[1] On January 5, 2011, the Company acquired Surgical Biologics, LLC. As a result, the Company recorded intangible assets for Customer & Supplier Relationships of $3,761,000, Patents & Know-How of $7,690,000, Licenses of $13,000, Trade Names & Trademarks of $1,008,000 and In-Process Research & Development of $25,000. During 2014 approximately $92,000 of additional costs associated with patents granted during the year were capitalized and included in Patents & Know- How subject to amortization.
[2] Capitalized external legal and other registration costs in connection with internally developed tissue-based patents that are pending. Once issued, the costs associated with a given patent will be included in Patents & Know-How under intangible assets subject to amortization.
[3] On January 29, 2007, the Company acquired a license from Shriners Hospitals for Children and University of South Florida Research Foundation, Inc. in the amount of $996,000. Within 30 days after the receipt by the Company of approval by the FDA allowing the sale of the first licensed product, the Company is required to pay an additional $200,000 to the licensor. Due to its contingent nature, this amount is not recorded as a liability. The Company will also be required to pay a royalty of 3% on all commercial sales revenue from the licensed products. The Company is also obligated to pay a $50,000 minimum annual royalty payment over the life of the license. As of December 31, 2014, this license had a remaining net book value of approximately $209,000.